The Pharmalot View

Ed Silverman

With his Pharmalot View column for STAT, Ed Silverman takes a step back from the 24/7/365 news cycle to offer commentary at the intersection of the pharmaceutical industry and politics. These well-researched pieces examined issues within the industry that have a tangible impact on patients, doctors and health care companies. His essay about the dangers of Sanofi’s vaccine to combat the dengue fever virus in the Philippines noted that, at a time when many people remain suspicious of vaccines, the incident raised the question of “whether the company moved too quickly because it needed a big seller.” In another column, Silverman found a loophole in the law designed to expose conflict-of-interest ties between doctors and drugmakers that may unduly influence medical practice and research; he urged Congress to fix the exception to the reporting requirements so as to increase transparency among under-the-radar companies. He wrote an open letter to Mike Pence criticizing the vice president’s “misguided” effort to pass a federal “right-to-try” law, which would allow terminally ill people access to experimental, potentially life-saving treatments. Concluded Silverman: “Your goal is admirable. Unfortunately, though, you’re peddling false hopes.”

Download Winning Entry
(PDF Format)

 

Photo Gallery

 
  • Space
  • Space
  • Space
  • Space